APA (7th ed.) Citation

Agarwal, A., & Mathur, S. B. (2022). Letter to the editor: Safety and immunogenicity of a novel recombinant rabies vaccine. Human vaccines & immunotherapeutics, 18(5), 2085472. https://doi.org/10.1080/21645515.2022.2085472

Chicago Style (17th ed.) Citation

Agarwal, Anurag, and Surendra Bahadur Mathur. "Letter to the Editor: Safety and Immunogenicity of a Novel Recombinant Rabies Vaccine." Human Vaccines & Immunotherapeutics 18, no. 5 (2022): 2085472. https://doi.org/10.1080/21645515.2022.2085472.

MLA (9th ed.) Citation

Agarwal, Anurag, and Surendra Bahadur Mathur. "Letter to the Editor: Safety and Immunogenicity of a Novel Recombinant Rabies Vaccine." Human Vaccines & Immunotherapeutics, vol. 18, no. 5, 2022, p. 2085472, https://doi.org/10.1080/21645515.2022.2085472.